Cargando…
Serum β-klotho is a potential biomarker in the prediction of clinical outcomes among patients with NSCLC
BACKGROUND: We aimed to investigate the β-klotho (KLB) expression in non-small cell lung cancer (NSCLC) and to determine its value as a novel molecular target for survival prognosis in patients with NSCLC. METHODS: The serum KLB concentrations in 50 patients with NSCLC and the 20 healthy persons wer...
Autores principales: | Zhou, Juan, Ben, Suqin, Xu, Tan, Xu, Liqin, Yao, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182533/ https://www.ncbi.nlm.nih.gov/pubmed/34164204 http://dx.doi.org/10.21037/jtd-21-798 |
Ejemplares similares
-
Soluble Klotho protein as a novel serum biomarker in patients with acromegaly
por: Dąbrowska, Anna M., et al.
Publicado: (2014) -
The controversy of klotho as a potential biomarker in chronic kidney disease
por: Yu, Li-Xia, et al.
Publicado: (2022) -
Serum Klotho Levels in Trained Athletes
por: Mostafidi, Elmira, et al.
Publicado: (2016) -
Measurement of Serum Klotho in Systemic Sclerosis
por: Talotta, Rossella, et al.
Publicado: (2017) -
Serum klotho: a potential predictor of cerebrovascular disease in hemodialysis patients
por: Wei, Honglan, et al.
Publicado: (2019)